Rivera-Melendez v. Pfizer Pharmaceuticals, LLC

730 F.3d 49, 97 Empl. Prac. Dec. (CCH) 44,915, 2013 WL 5290017, 197 L.R.R.M. (BNA) 2088, 2013 U.S. App. LEXIS 19398
CourtCourt of Appeals for the First Circuit
DecidedSeptember 20, 2013
Docket12-1023
StatusPublished
Cited by8 cases

This text of 730 F.3d 49 (Rivera-Melendez v. Pfizer Pharmaceuticals, LLC) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rivera-Melendez v. Pfizer Pharmaceuticals, LLC, 730 F.3d 49, 97 Empl. Prac. Dec. (CCH) 44,915, 2013 WL 5290017, 197 L.R.R.M. (BNA) 2088, 2013 U.S. App. LEXIS 19398 (1st Cir. 2013).

Opinion

LIPEZ, Circuit Judge.

This case requires us to determine whether the “escalator principle” and “reasonable certainty” test governing reinstatement claims under the Uniformed Services Employment and Reemployment Rights Act of 1994 (“USERRA”) apply to non-automatic, “discretionary” promotions. The district court found that they do not, and used this conclusion to reject plaintiff Luis Rivera-Meléndez’s USERRA reinstatement claim pursuant to 38 U.S.C. §§ 4312 and 4313 and award summary judgment to defendant, Pfizer Pharmaceuticals, LLC (“Pfizer”). Because we conclude that the escalator principle and rea *51 sonable certainty test apply regardless of whether the promotion at issué is automatic or non-automatic, we vacate the district court’s judgment and remand.

I.

A. Background

We summarize the relevant facts in the light most favorable to Rivera, the party against whom summary judgment was granted. Barclays Bank PLC v. Poynter, 710 F.3d 16, 18 (1st Cir.2013).

Luis Rivera-Meléndez (“Rivera”) earned his associate’s degree in chemistry from the Technological Institute of Manat in 1993 and a bachelor’s degree in liberal arts from the Pontifical Catholic University at Arecibo in 2010. He began working at Pfizer’s pharmaceutical manufacturing facility in Barceloneta, Puerto Rico in 1994. Initially employed as a Chemical Operator Trainee, Rivera received several promotions, including a 2004 promotion to Active Pharmaceutical Ingredient (“API”) Group Leader. The API Group Leader position — which has since been eliminated — was an hourly, non-exempt position under the supervision of the exempt API Supervisor and API Manager. 1

Rivera also serves his country as a member of the United States Naval Reserve (“Navy”). During his career at Pfizer, he has been called twice into active duty service. On October 11, 2008, Rivera received notice that he was being called to active duty in Iraq. He promptly notified Pfizer’s Senior Human Resources Specialist that he needed to take military leave. After attending pre-mobilization training, Rivera commenced his active duty service on December 5, 2008. His tour of duty concluded on October 21, 2009.

In February 2009, Pfizer restructured its API Department. As part of this restructuring, Pfizer eliminated the API Group Leader position held by Rivera and replaced it with two separate classifications: API Team Leader and API Service Coordinator. Pfizer management held a meeting with the API Group Leaders at the Barceloneta facility and informed them that they could apply for the exempt API Team Leader position, for which seven job openings would be posted. The API Group Leaders were informed that if they were not among those selected for the API Team Leader position, they would have three alternatives: (1) to apply to the new, non-exempt API Service Coordinator position; (2) to be demoted to the Senior API Operator position; or (3) to participate in a voluntary separation option.

The API Team Leader positions were posted in March 2009, seven months before Rivera returned to Pfizer. The position originally required, inter alia, a Bachelor’s Degree in Science or Business Administration, at least five years of experience in API manufacturing, and at least five years in a supervisory or interdisciplinary team environment handling multiple tasks. Pfizer Senior Human Resources Specialist Lissette Guerra-Sierra testified in a deposition that an estimated sixteen to seventeen people applied for the seven API Team Leader vacancies. After a first round of interviews, Pfizer modified the criteria so that API Group Leaders without bachelor’s degrees could qualify for the position, subject to their completing the degree requirement within a specified period of time.

*52 The seven API Team Leader positions were filled by six of the former API Group Leaders and one Senior API Operator. 2 None of the six API Group Leaders who were promoted satisfied the original bachelor’s degree requirement. Of the API Group Leaders not selected for the API Team Leader position, one, Luis Bravo, was appointed' to special projects under the supervision of the API Manager pending the approval of the new API Service Coordinator position, while two others were demoted to the API Senior Operator position.

Upon being discharged from active military service, Rivera contacted Pfizer to request reinstatement. He returned to work on October 22, 2009. Rivera met with the API Manager, who told him that he was reinstated as an API Group Leader. However, because the API Group Leader position had been effectively eliminated by the time he returned to Pfizer, Rivera, like Luis Bravo, was assigned to “special tasks” under the supervision of the API Manager. Although Rivera’s salary and benefits were not altered, he had reduced job responsibilities while assigned to the “special tasks” role.

On May 17, 2010, Rivera was appointed to the API Service Coordinator position after the creation of the position had been officially approved by Pfizer. Three other former API Group Leaders were appointed to the API Service Coordinator position as well. Rivera continued to receive the same compensation and benefits he had received as an API Group Leader, though he had fewer job responsibilities. Specifically, Rivera stated in his deposition that he no longer had the limited supervisory duties with which he was charged as an API Group Leader when supervisors were unavailable. Rivera also testified that he would have liked the opportunity to apply for the API Team Leader position, and that he felt he was qualified for the position.

B. Procedural History

Rivera and the conjugal partnership comprised of Rivera and his wife filed suit against Pfizer on January 11, 2010, asserting USERRA and pendent state law claims. 3 Rivera’s USERRA claims alleged violations of the statute’s anti-discrimination and reinstatement provisions. Specifically, Rivera argued that Pfizer had violated his rights by, inter alia, delaying payment of his differential pay and pay raise, refusing to pay him a 2009 Christmas bonus, failing to provide him with an opportunity to apply for the API Team Leader position, and subjecting him to a hostile work environment based on his military service. Rivera also alleged that he was entitled to be rehired to a supervisory (i.e., the API Team Leader) position upon his return from active duty.

Pfizer moved for summary judgment on August 23, 2011. 4 The district court *53 granted Pfizer’s motion as to nearly all of Rivera’s USERRA claims. 5 Among the claims the district court rejected were those Rivera brought pursuant to 38 U.S.C. §§ 4312

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Alves v. City of Gloucester
D. Massachusetts, 2022
Leroy McGill v. David Shinn
16 F.4th 666 (Ninth Circuit, 2021)
Dale Huhmann v. Federal Express Corp.
874 F.3d 1102 (Ninth Circuit, 2017)
Mace v. Willis
259 F. Supp. 3d 1007 (D. South Dakota, 2017)
Vahey v. General Motors Company
985 F. Supp. 2d 51 (District of Columbia, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
730 F.3d 49, 97 Empl. Prac. Dec. (CCH) 44,915, 2013 WL 5290017, 197 L.R.R.M. (BNA) 2088, 2013 U.S. App. LEXIS 19398, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rivera-melendez-v-pfizer-pharmaceuticals-llc-ca1-2013.